Rebecca Fitzgerald is Professor of Cancer Prevention at the University of Cambridge and Director, Early Cancer Institute.

She still practices medicine as an Honorary Consultant in Gastroenterology at Addenbrooke's Hospital, Cambridge. 

She studied Medicine at Cambridge University and gained her MD in 1997 following a period of research at Stanford University, California, with Professor George Triadafilopoulos. Her postdoctoral training took place at the Department of Adult and Paediatric Gastroenterology, St Barts and The Royal London School of Medicine and Dentistry with Professor Michael Farthing, funded by an MRC Clinician Scientist award. She returned to Cambridge in 2001 to form her own group and since then her work has been funded by CRUK and MRC. In 2022 she founded a new institute to bring together clinicians and scientists from multiple disciplines to make breakthroughs in detecting cancer earlier.

The focus of her research group is understand how cancer of the oesophagus and stomach develops and use this to develop new diagnosis and screening tests. Rebecca was awarded the prestigious Westminster medal and prize for her first proof-of-concept work on the CytospongeTM and associated assays for diagnosing precancer of the oesophagus, Barrett oesophagus, in 2004. She received a Lister Prize Fellowship in 2008 and in 2013 was awarded an NIHR Research Professorship to facilitate translational research for patient benefit. She was elected a Fellow of the Academy of Medical Sciences in 2013, in 2021 she was awarded the Don Listwin Award for Outstanding Contribution to Cancer Early Detection and she received an OBE for services to cancer medicine in 2022.

Rebecca has a wealth of lecturing experience including radio broadcasts for BBC Radio 4 and ABC Radio Australia, Health of the Nation. Rebecca is a Fellow of Trinity College Cambridge and committed to teaching and inspiring the next generation of clinical researchers.
 

Professor Jean Abraham is Director of the Cambridge Breast Cancer Research Unit, and an Academic Honorary Consultant in Medical Oncology in Cambridge. She co-leads the Integrated Cancer Medicine (ICM) theme in the Cancer Research UK Cambridge Centre, with oversight of the Cancer Molecular Diagnostics Laboratory, ICM Clinical Trials and Tissue Bank Rapid Response Team. Jean is also deputy theme lead for Cancer at the Cambridge NIHR Biomedical Research Campus. She is part of the national NIHR Clinical Studies Group for Breast Cancer and part of the NCRI Working Party for Early Disease. She graduated from the University of Liverpool Medical School and trained in Internal Medicine and Oncology at the University of Cambridge. She was awarded a National CRUK PhD Fellowship, receiving her PhD in Breast Cancer Pharmacogenetics from the University of Cambridge (2011). In 2017 she was awarded the BioBeat Award for Top 50 Females in UK BioBusiness and Healthcare and a Royal Society Award to enable closer links between academics/scientists and policy makers.

The goal of her research is to identify better ways to personalise breast cancer treatments, avoiding overtreatment and unnecessary toxicity and providing better clinical outcomes.